COGT logo

Cogent Biosciences, Inc. (COGT) EBIT

annual EBIT:

-$275.94M-$67.81M(-32.58%)
December 31, 2024

Summary

  • As of today (July 27, 2025), COGT annual earnings before interest & taxes is -$275.94 million, with the most recent change of -$67.81 million (-32.58%) on December 31, 2024.
  • During the last 3 years, COGT annual EBIT has fallen by -$200.39 million (-265.24%).
  • COGT annual EBIT is now -4085.97% below its all-time high of -$6.59 million, reached on December 31, 2015.

Performance

COGT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

quarterly EBIT:

-$74.93M-$1.20M(-1.63%)
March 31, 2025

Summary

  • As of today (July 27, 2025), COGT quarterly earnings before interest & taxes is -$74.93 million, with the most recent change of -$1.20 million (-1.63%) on March 31, 2025.
  • Over the past year, COGT quarterly EBIT has dropped by -$12.53 million (-20.08%).
  • COGT quarterly EBIT is now -3445.22% below its all-time high of $2.24 million, reached on December 31, 2019.

Performance

COGT quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

TTM EBIT:

-$288.47M-$12.53M(-4.54%)
March 31, 2025

Summary

  • As of today (July 27, 2025), COGT TTM earnings before interest & taxes is -$288.47 million, with the most recent change of -$12.53 million (-4.54%) on March 31, 2025.
  • Over the past year, COGT TTM EBIT has dropped by -$61.17 million (-26.91%).
  • COGT TTM EBIT is now -4653.14% below its all-time high of -$6.07 million, reached on March 31, 2017.

Performance

COGT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

COGT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-32.6%-20.1%-26.9%
3 y3 years-265.2%-138.5%-206.3%
5 y5 years-757.5%-1120.2%-1135.9%

COGT EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-265.2%at low-109.0%+0.6%-155.9%at low
5 y5-year-757.5%at low-912.2%+0.6%-1235.9%at low
alltimeall time-4086.0%at low-3445.2%+0.6%-4653.1%at low

COGT EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$74.93M(+1.6%)
-$288.47M(+4.5%)
Dec 2024
-$275.94M(+32.6%)
-$73.73M(-2.2%)
-$275.94M(+6.0%)
Sep 2024
-
-$75.41M(+17.1%)
-$260.43M(+6.5%)
Jun 2024
-
-$64.39M(+3.2%)
-$244.60M(+7.6%)
Mar 2024
-
-$62.40M(+7.2%)
-$227.30M(+9.2%)
Dec 2023
-$208.13M(+40.8%)
-$58.23M(-2.3%)
-$208.13M(+7.5%)
Sep 2023
-
-$59.58M(+26.5%)
-$193.65M(+13.3%)
Jun 2023
-
-$47.09M(+8.9%)
-$170.89M(+7.0%)
Mar 2023
-
-$43.24M(-1.2%)
-$159.66M(+8.0%)
Dec 2022
-$147.84M(+95.7%)
-$43.74M(+18.8%)
-$147.84M(+14.0%)
Sep 2022
-
-$36.82M(+2.7%)
-$129.73M(+15.1%)
Jun 2022
-
-$35.85M(+14.1%)
-$112.73M(+19.7%)
Mar 2022
-
-$31.42M(+22.5%)
-$94.17M(+24.6%)
Dec 2021
-$75.55M(+114.1%)
-$25.64M(+29.4%)
-$75.55M(+23.1%)
Sep 2021
-
-$19.82M(+14.6%)
-$61.37M(+18.4%)
Jun 2021
-
-$17.29M(+35.1%)
-$51.84M(+23.6%)
Mar 2021
-
-$12.80M(+11.7%)
-$41.95M(+18.9%)
DateAnnualQuarterlyTTM
Dec 2020
-$35.29M(+9.7%)
-$11.46M(+11.3%)
-$35.29M(+63.4%)
Sep 2020
-
-$10.29M(+39.0%)
-$21.59M(-7.5%)
Jun 2020
-
-$7.40M(+20.6%)
-$23.34M(-11.9%)
Mar 2020
-
-$6.14M(-374.2%)
-$26.48M(-17.7%)
Dec 2019
-$32.18M(-10.6%)
$2.24M(-118.6%)
-$32.18M(-25.9%)
Sep 2019
-
-$12.04M(+14.2%)
-$43.42M(+3.5%)
Jun 2019
-
-$10.54M(-11.0%)
-$41.96M(+2.7%)
Mar 2019
-
-$11.84M(+31.5%)
-$40.86M(+13.5%)
Dec 2018
-$36.01M(+37.7%)
-$9.00M(-14.9%)
-$36.01M(+6.3%)
Sep 2018
-
-$10.58M(+12.0%)
-$33.88M(+11.2%)
Jun 2018
-
-$9.44M(+35.1%)
-$30.48M(+12.6%)
Mar 2018
-
-$6.99M(+1.5%)
-$27.07M(+3.5%)
Dec 2017
-$26.15M(+37.1%)
-$6.88M(-4.0%)
-$26.15M(+35.7%)
Sep 2017
-
-$7.17M(+18.8%)
-$19.27M(+59.2%)
Jun 2017
-
-$6.03M(-0.6%)
-$12.10M(+99.4%)
Mar 2017
-
-$6.07M
-$6.07M
Dec 2016
-$19.07M(+189.3%)
-
-
Dec 2015
-$6.59M
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual EBIT year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly EBIT year-on-year change?
  • What is Cogent Biosciences, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM EBIT year-on-year change?

What is Cogent Biosciences, Inc. annual earnings before interest & taxes?

The current annual EBIT of COGT is -$275.94M

What is the all time high annual EBIT for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual earnings before interest & taxes is -$6.59M

What is Cogent Biosciences, Inc. annual EBIT year-on-year change?

Over the past year, COGT annual earnings before interest & taxes has changed by -$67.81M (-32.58%)

What is Cogent Biosciences, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of COGT is -$74.93M

What is the all time high quarterly EBIT for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly earnings before interest & taxes is $2.24M

What is Cogent Biosciences, Inc. quarterly EBIT year-on-year change?

Over the past year, COGT quarterly earnings before interest & taxes has changed by -$12.53M (-20.08%)

What is Cogent Biosciences, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of COGT is -$288.47M

What is the all time high TTM EBIT for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM earnings before interest & taxes is -$6.07M

What is Cogent Biosciences, Inc. TTM EBIT year-on-year change?

Over the past year, COGT TTM earnings before interest & taxes has changed by -$61.17M (-26.91%)
On this page